These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10591387)

  • 1. Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
    Steinberg D; Gotto AM
    JAMA; 1999 Dec; 282(21):2043-50. PubMed ID: 10591387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of the cholesterol controversy in Britain.
    Thompson GR
    QJM; 2009 Feb; 102(2):81-6. PubMed ID: 19042967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins have offered great benefits. 2002.
    Yamamoto A
    Atheroscler Suppl; 2004 Oct; 5(3):35-7. PubMed ID: 15531272
    [No Abstract]   [Full Text] [Related]  

  • 6. The statins in preventive cardiology.
    Steinberg D
    N Engl J Med; 2008 Oct; 359(14):1426-7. PubMed ID: 18832243
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    Atheroscler Suppl; 2004 Oct; 5(3):51-5. PubMed ID: 15531275
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis.
    Rosenfeld L
    Arch Pathol Lab Med; 1989 Oct; 113(10):1101-10. PubMed ID: 2679486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol lowering and endothelial function.
    Vogel RA
    Am J Med; 1999 Nov; 107(5):479-87. PubMed ID: 10569303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
    Ansell BJ; Watson KE; Fogelman AM
    JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 17. State-of-the-art update and review: clinical trials of lipid-lowering agents.
    Kwiterovich PO
    Am J Cardiol; 1998 Dec; 82(12A):3U-17U; discussion 39U-41U. PubMed ID: 9915657
    [No Abstract]   [Full Text] [Related]  

  • 18. The pathogenesis of arteriosclerosis.
    Andrus EC; Allen EV; Merritt HH; Duff GL; Moore RA; Kendall FE; Shumacker HB; Levy RL; Wright IS
    Int J Epidemiol; 2015 Dec; 44(6):1791-3. PubMed ID: 27088150
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons from cholesterol-lowering trials.
    Smith SC
    Am J Med; 1998 Jun; 104(6A):28S-32S. PubMed ID: 9684849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995.
    Oliver M; Poole-Wilson P; Shephered J; Tikkanen M
    Atheroscler Suppl; 2004 Oct; 5(3):89-90. PubMed ID: 15531280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.